Last reviewed · How we verify

NCT07143903: Women Power

Normal Delivery : Optimization of Women Power Using Artificial Intelligence

Completed NA Last updated 20 November 2025
What this trial tests

NA trial testing artificial application in Smart Normal Labor in 216 participants. Completed in 25 October 2025.

Timeline
28 August 2024
Primary endpoint
20 October 2025
25 October 2025

Quick facts

Lead sponsorDelta University for Science and Technology
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposeother
Enrollment216
Start date28 August 2024
Primary completion20 October 2025
Estimated completion25 October 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Delta University for Science and Technology

Who can join

Adults 16 to 50, female only, with Smart Normal Labor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

As the global population continues to rise, the demand for efficient and effective maternal healthcare solutions becomes increasingly urgent. According to the United Nations, the world population is projected to reach approximately 9.7 billion by 2050, with a significant increase in the number of pregnancies and births. This demographic shift underscores the necessity for innovative healthcare technologies that can address the unique challenges faced by expectant mothers during childbirth. The first stage of labor, which involves the onset of contractions and the gradual dilation of the cervix, is a critical period that requires careful monitoring and support. Many women experience anxiety and uncertainty during this time, often exacerbated by a lack of accessible information about labor progression. A lack of information and support during this pivotal time can lead to stress, impacting both maternal well-being and the overall labor experience. To address these challenges, the integration of artificial intelligence (AI) and mobile health technologies offers a transformative opportunity to empower women. Traditional methods of labor monitoring can be resource-intensive and may not provide the real-time insights that mothers need to make informed decisions about their care. In this context, the integration of artificial intelligence (AI) and mobile health technologies presents a transformative opportunity. By developing a mobile application specifically designed to monitor the first stage of labor, we can empower expectant mothers with real-time data and personalized guidance. This application aims to track contractions, analyze symptoms, and provide educational resources, ultimately enhancing the labor experience for women .Furthermore, the application will not only serve individual users but also support healthcare providers by offering valuable insights into patient progress. With data-driven analytics, practitioners can make more informed decisions, allocate resources more efficiently, and improve overall care delivery. This proposal outlines the development and evaluation of an AI-powered labor monitoring application that addresses the challenges posed by a growing population and increasing childbirth rates. By focusing on validity and reliability in our methodology, this project aims to contribute to the evolving field of digital health, promoting better outcomes for mothers and their newborns in an increasingly complex healthcare landscape. By developing a mobile application specifically designed to monitor the first stage of labor, we aim to equip expectant mothers with real-time data and personalized guidance. This application will track contractions, analyze symptoms, and provide educational resources tailored to individual needs. By empowering women with knowledge and insights about their labor progression, the app will foster confidence and enable informed decision-making regarding their care. Furthermore, the application will facilitate communication between expectant mothers and healthcare providers, ensuring that women receive timely support and intervention when necessary. By utilizing predictive analytics, the app can alert users and healthcare professionals to concerning patterns, thus improving responsiveness and care outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Delta University for Science and Technology trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07143903.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing